Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

Sun Pharmaceutical Industries Inc recalls Zolpidem Tartrate Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Products
  • Zolpidem Tartrate Extended-Release Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
1220 bottles
About this recall
Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-307-88.